Healthcare Spending on Branded Prescription Drugs Continues to Rise Despite Availability of More Generics

According to a new study conducted by the Blue Cross Blue Shield Association (BCBSA), the payer’s commercially insured members spend $100 billion on branded prescription drugs each year, compared to just shy of $80 billion on generics.